Cancer Communications
indexed by SCI
BMC


LETTER TO THE EDITOR
Nut and peanut butter consumption and risk of prostate cancer in the NIH-AARP diet and health study
Mimi Ton, Leah M. Ferrucci, Stephanie J. Weinstein, Maryam Hashemian, Demetrius Albanes, Jiaqi Huang
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12230
REVIEW
Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
Shijie Shang, Jie Liu, Vivek Verma, Meng Wu, James Welsh, Jinming Yu, Dawei Chen
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12226
LETTER TO THE EDITOR
Clinical characteristics and outcomes of Chinese patients with KRAS-mutant non-small cell lung cancer after chemotherapy
Yawen Zheng, Qinghua Lai, Hanxi Zhao, Xiaolin Li, Xiaorong Sun, Ligang Xing
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12227
REVIEW
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
Zi-Hang Chen, Li Lin, Chen-Fei Wu, Chao-Feng Li, Rui-Hua Xu, Ying Sun
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/6/2021   doi:10.1002/cac2.12215
ORIGINAL ARTICLE
A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors
Lili Lu, Christina S. Mullins, Clemens Schafmayer, Sebastian Zei?ig, Michael Linnebacher
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/25/2021   doi:10.1002/cac2.12220
RESEARCH HIGHLIGHT
Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy
Xue Yang, Bingjing Wang, Xuetao Cao
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/23/2021   doi:10.1002/cac2.12222
ORIGINAL ARTICLE
P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer
Yin-Wei Cheng, Fa-Min Zeng, Da-Jia Li, Shao-Hong Wang, Jian-Zhong He, Zhen-Chang Guo, Ping-Juan Nie, Zhi-Yong Wu, Wen-Qi Shi, Bing Wen, Xiu-E Xu, Lian-Di Liao, Zhi-Mao Li, Jian-Yi Wu, Jun Zhan, Hong-Quan Zhang, Zhi-Jie Chang, Kai Zhang, Li-Yan Xu, En-Min Li
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/23/2021   doi:10.1002/cac2.12221
LETTER TO THE EDITOR
Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter
Beiping Miao,Chaoyang Zhang,Nadine Stroh,Lukas Brenner,Katrin Hufnagel,J?rg D. Hoheisel,Obul Reddy Bandapalli
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/14/2021   doi:10.1002/cac2.12216
RESEARCH HIGHLIGHT
Prognostic value of single-nucleotide polymorphisms for extranodal natural killer/T-cell lymphoma: the identification of risk factors in the molecular era
Sang Eun Yoon,Won Seog Kim
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/14/2021   doi:10.1002/cac2.12212
ORIGINAL ARTICLE
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer
Chong Wu,Jingjing Zhu,Austin King,Xiaoran Tong,Qing Lu,Jong Y. Park,Liang Wang,Guimin Gao,Hong-Wen Deng,Yaohua Yang,Karen E. Knudsen,Timothy R. Rebbeck,Jirong Long,Wei Zheng,Wei Pan,David V. Conti,Christopher A Haiman,Lang Wu
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/14/2021   doi:10.1002/cac2.12205

<<    Page 21 of 62  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China